Just because Wall Street likes a stock doesn't mean it's a great pick. In some cases, they're so optimistic that their price ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Socially responsible companies are businesses that integrate social and environmental considerations into their core operations and decision-making processes.

Federal officials announced Ozempic, Wegovy and 13 other drugs are on a list of medications the government is targeting for ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

London-based megabank HSBC may be recognizable to some U.S. consumers, but elsewhere, it is a well-known name that provides ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy ... until they can afford to buy the next batch of drugs.” ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...